Abstract:The old alcohol-aversion drug disulfiram (DSF) has aroused wide attention as a drug repurposing strategy in terms of cancer therapy because of the high antitumor efficacy in combination with copper ion. However, numerous defects of DSF (e.g., the short half-life and acid instability) have limited the application in cancer treatment. Cu(DDC) 2 , the complex of diethyldithiocarbamate (DDC, DSF metabolite) and Cu 2+ , have been proven as the vital active component on cancer, which have aroused the attention of researchers from DSF to Cu(DDC) 2 . However, the poor water solubility of Cu(DDC) 2 increase more difficulties to the treatment and in-depth investigations of Cu(DDC) 2 . In this study, sphingomyelin (SM)-based PEGylated liposomes (SM/Chol/DSPE-mPEG 2000 (55:40:5, mole%)) were produced as the carriers for Cu(DDC) 2 delivery to enhance the water solubility. DDC was added to Cu-containing liposomes with a higher encapsulation efficiency of more than 90%, and it reacted with Cu 2+ to synthesize Cu(DDC) 2 . Due to the high phase transition temperature of SM and strong intermolecular hydrogen bonds with cholesterol, SM-based liposomes would be conducive to enhancing the stability of Cu(DDC) 2 and preventing drug leakage during delivery. As proven by pharmacokinetic studies, loading Cu(DDC) 2 into liposomes improve bioavailability, and the area under the curve (AUC 0-t ) and the mean elimination half-life (t 1/2 ) increased 1.9-time and 1.3-time to those of free Cu(DDC) 2 , respectively. Furthermore, the anticancer effect of Cu(DDC) 2 was enhanced by the liposomal encapsulation, thus resulting in remarkable cell apoptosis in vitro and a tumor-inhibiting rate of 77.88% in vivo . Thus, it was concluded that Cu(DDC) 2 liposomes could be promising in cancer treatment.

Liposomes Assembled from A Dual Drug-Tailed Phospholipid for Cancer Therapy

Dual-vectors of Anti-Cancer Drugs and Genes Based on Ph-Sensitive Micelles Self-Assembled from Hybrid Polypeptide Copolymers

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Sphingomyelin-based PEGylation Cu(DDC) 2 Liposomes Prepared via the Dual Function of Cu 2+ for Cancer Therapy: Facilitating DDC Loading and Exerting Synergistic Antitumor Effects

Potent cancer therapy by liposome microstructure tailoring with active-to-passive targeting and shell-to-core thermosensitive features

Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide

Dual Drug-Loaded Nanoliposomes Encapsulating Curcumin and 5-Fluorouracil with Advanced Medicinal Applications: Self-Monitoring and Antitumor Therapy

Micelles via self-assembly of amphiphilic beta-cyclodextrin block copolymers as drug carrier for cancer therapy

Dendritic Lipopeptide Liposomes Decorated with Dual-Targeted Proteins

Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug-Drug Conjugate for Cancer Therapy.

Enhanced Anticancer Efficacy of Dual Drug-Loaded Self-Assembled Nanostructured Lipid Carriers Mediated by pH-Responsive Folic Acid and Human-Derived Cell Penetrating Peptide dNP2

Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy

Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy

Dachpt-Loaded Unimolecular Micelles Based on Hydrophilic Dendritic Block Copolymers for Enhanced Therapy of Lung Cancer

Liposomes Coated with Novel Synthetic Bifunctional Chitosan Derivatives as Potential Carriers of Anticancer Drugs

Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.

Combinatorial Targeting Polymeric Micelles for Anti-Tumor Drug Delivery.

Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy

Dual-Functional Drug Liposomes in Treatment of Resistant Cancers

Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery.